Hexaxim regulatory update

EMA's CHMP recommended approval of Hexaxim outside the EU as a primary and booster vaccination for infants and toddlers against diphtheria, tetanus, pertussis, hepatitis B, polio and Haemophilus influenzae type B. Sanofi's Sanofi Pasteur S.A. vaccines unit and Merck are jointly developing the combination vaccine. ...